Literature DB >> 25920008

Proteomics-level analysis of myelin formation and regeneration in a mouse model for Vanishing White Matter disease.

Irit Gat-Viks1, Tamar Geiger2, Mali Barbi1, Gali Raini1, Orna Elroy-Stein1,3.   

Abstract

Vanishing white matter (VWM) is a recessive neurodegenerative disease caused by mutations in translation initiation factor eIF2B and leading to progressive brain myelin deterioration, secondary axonal damage, and death in early adolescence. Eif2b5(R132H/R132H) mice exhibit delayed developmental myelination, mild early neurodegeneration and a robust remyelination defect in response to cuprizone-induced demyelination. In the current study we used Eif2b5(R132H/R132H) mice for mass-spectrometry analyses, to follow the changes in brain protein abundance in normal- versus cuprizone-diet fed mice during the remyelination recovery phase. Analysis of proteome profiles suggested that dysregulation of mitochondrial functions, altered proteasomal activity and impaired balance between protein synthesis and degradation play a role in VWM pathology. Consistent with these findings, we detected elevated levels of reactive oxygen species in mutant-derived primary fibroblasts and reduced 20S proteasome activity in mutant brain homogenates. These observations highlight the importance of tight translational control to precise coordination of processes involved in myelin formation and regeneration and point at cellular functions that may contribute to VWM pathology. Eif2b5(R132H/R132H) mouse model for vanishing white matter (VWM) disease was used for mass spectrometry of brain proteins at two time points under normal conditions and along recovery from cuprizone-induced demyelination. Comparisons of proteome profiles revealed the importance of mitochondrial function and tight coordination between protein synthesis and degradation to myelination formation and regeneration, pointing at cellular functions that contribute to VWM pathology.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  VWM; cuprizone; eIF2B; myelination; proteomics; remyelination

Mesh:

Substances:

Year:  2015        PMID: 25920008      PMCID: PMC4499455          DOI: 10.1111/jnc.13142

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  40 in total

Review 1.  Sample preparation methods for mass spectrometric peptide mapping directly from 2-DE gels.

Authors:  O N Jensen; M Wilm; A Shevchenko; M Mann
Journal:  Methods Mol Biol       Date:  1999

Review 2.  Vanishing white matter disease.

Authors:  Marjo S van der Knaap; Jan C Pronk; Gert C Scheper
Journal:  Lancet Neurol       Date:  2006-05       Impact factor: 44.182

Review 3.  mTOR signaling in growth control and disease.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  Cell       Date:  2012-04-13       Impact factor: 41.582

Review 4.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

5.  Prenatal stress and neonatal rat brain development.

Authors:  D L A Van den Hove; H W M Steinbusch; A Scheepens; W D J Van de Berg; L A M Kooiman; B J G Boosten; J Prickaerts; C E Blanco
Journal:  Neuroscience       Date:  2005-10-20       Impact factor: 3.590

Review 6.  The large spectrum of eIF2B-related diseases.

Authors:  A Fogli; O Boespflug-Tanguy
Journal:  Biochem Soc Trans       Date:  2006-02       Impact factor: 5.407

7.  Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes.

Authors:  Olaf Goldbaum; Grit Vollmer; Christiane Richter-Landsberg
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

8.  Human myelin proteome and comparative analysis with mouse myelin.

Authors:  Akihiro Ishii; Ranjan Dutta; Greg M Wark; Sun-Il Hwang; David K Han; Bruce D Trapp; Steven E Pfeiffer; Rashmi Bansal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-13       Impact factor: 11.205

9.  Evidence for aerobic ATP synthesis in isolated myelin vesicles.

Authors:  Silvia Ravera; Isabella Panfoli; Daniela Calzia; Maria Grazia Aluigi; Paolo Bianchini; Alberto Diaspro; Gianluigi Mancardi; Alessandro Morelli
Journal:  Int J Biochem Cell Biol       Date:  2009-01-22       Impact factor: 5.085

10.  A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.

Authors:  Liraz Marom; Igor Ulitsky; Yuval Cabilly; Ron Shamir; Orna Elroy-Stein
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

View more
  16 in total

Review 1.  Glial Contributions to Neural Function and Disease.

Authors:  Matthew N Rasband
Journal:  Mol Cell Proteomics       Date:  2015-09-04       Impact factor: 5.911

2.  eIF2B Mutations Cause Mitochondrial Malfunction in Oligodendrocytes.

Authors:  Melisa Herrero; Shir Mandelboum; Orna Elroy-Stein
Journal:  Neuromolecular Med       Date:  2019-05-27       Impact factor: 3.843

Review 3.  Regulation and function of elF2B in neurological and metabolic disorders.

Authors:  Filipe M Hanson; Rachel E Hodgson; Madalena I Ribeiro de Oliveira; K Elizabeth Allen; Susan Gerarda Campbell
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

4.  Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.

Authors:  Silvia Ravera; Martina Bartolucci; Patrizia Garbati; Sara Ferrando; Daniela Calzia; Paola Ramoino; Maurizio Balestrino; Alessandro Morelli; Isabella Panfoli
Journal:  Mol Neurobiol       Date:  2015-12-16       Impact factor: 5.590

5.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

6.  Role of myelin sheath energy metabolism in neurodegenerative diseases.

Authors:  Silvia Ravera; Isabella Panfoli
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

7.  Partial Immunoblotting of 2D-Gels: A Novel Method to Identify Post-Translationally Modified Proteins Exemplified for the Myelin Acetylome.

Authors:  Kathrin Kusch; Marina Uecker; Thomas Liepold; Wiebke Möbius; Christian Hoffmann; Heinz Neumann; Hauke B Werner; Olaf Jahn
Journal:  Proteomes       Date:  2017-01-12

8.  Mitochondrial malfunction in vanishing white matter disease: a disease of the cytosolic translation machinery.

Authors:  Orna Elroy-Stein
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

9.  EIF2B2 mutations in vanishing white matter disease hypersuppress translation and delay recovery during the integrated stress response.

Authors:  Stephanie L Moon; Roy Parker
Journal:  RNA       Date:  2018-04-09       Impact factor: 4.942

10.  Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy.

Authors:  Andrea Atzmon; Melisa Herrero; Reut Sharet-Eshed; Yocheved Gilad; Hanoch Senderowitz; Orna Elroy-Stein
Journal:  Front Mol Neurosci       Date:  2018-09-18       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.